Description
A synthetic GNRH agonist; binds to GNRHR (Ki = 0.2 nM in CHO cells expressing the human receptor); stimulates oxytocin and vasopressin release ex vivo from the isolated rat hypothalamo-neurohypophysial system (100 nM); initial dose of 100 μg stimulates acute increases in LH, FSH, and testosterone serum levels (50-, 2.5-, and 15-fold, respectively), while chronic treatment leads to 95% decreases in LH and FSH responses in rhesus monkeys
Formal name: 6-[1-(phenylmethyl)-D-histidine]-9-(N-ethyl-L-prolinamide)-1-9-luteinizing hormone-releasing factor (swine), acetate
Synonyms: [(ImBzl)-d-His6,Pro9-NET]-LHRH|[Des-Gly10,D-His(Bzl)6,Pro-NHEt9]-LHRH|[Des-Gly10,D-His(Bzl)6]-LHRHethyl amide
Molecular weight: 1,323.50
CAS: 220810-26-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Hormones & Receptors||Research Area|Endocrinology & Metabolism|Reproductive Biology